Does DEGARELIX Cause Interstitial lung disease? 109 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Interstitial lung disease have been filed in association with DEGARELIX (FIRMAGON). This represents 2.9% of all adverse event reports for DEGARELIX.
109
Reports of Interstitial lung disease with DEGARELIX
2.9%
of all DEGARELIX reports
16
Deaths
72
Hospitalizations
How Dangerous Is Interstitial lung disease From DEGARELIX?
Of the 109 reports, 16 (14.7%) resulted in death, 72 (66.1%) required hospitalization, and 9 (8.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Injection site swelling (183)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DEGARELIX Alternatives Have Lower Interstitial lung disease Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM